Literature DB >> 12645947

Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages.

Deborah Greene Nguyen1, James E K Hildreth.   

Abstract

The human immunodeficiency virus (HIV) is an enveloped virus whose surface glycoprotein gp120 binds CD4 on target cell membranes to initiate infection. About half of the carbohydrates on gp120 are terminally mannosylated, a pattern common to many pathogens. We have examined the ability of macrophage mannose receptor (MMR) on primary monocyte-derived macrophages to bind HIV and facilitate its transmission to T cells. We adapted the tyramide signal amplification system for fluorescence detection of HIV bound to macrophages. Our data show that approximately 60% of the initial association of HIV with macrophages that lack expression of DC-SIGN (a dendritic cell-specific ICAM-3 receptor/HIV-1-binding protein) is MMR mediated, as evidenced by inhibition with mannan, D-mannose, EDTA, and soluble mannose-binding lectin, but not by D-galactose. This inhibition is not seen in cells that lack MMR. Macrophages are able to mediate transmission of bound HIV to co-cultured T cells, and this transmission is blocked up to 80% by inhibitors of MMR binding. Unlike virus bound to DC-SIGN, macrophage-bound HIV has a slightly lower half-life compared to free virus, with no transmission in co-culture observed beyond 24 h after virus binding to macrophages. Results obtained with endocytosis inhibitors indicate that this decrease in viral longevity is due to rapid internalization of macrophage-bound HIV. Together, these results suggest a substantial role for MMR in the binding and transmission of HIV-1 by macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645947     DOI: 10.1002/immu.200310024

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  89 in total

Review 1.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

2.  DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus.

Authors:  Andrea Marzi; Thomas Gramberg; Graham Simmons; Peggy Möller; Andrew J Rennekamp; Mandy Krumbiegel; Martina Geier; Jutta Eisemann; Nadine Turza; Bertrand Saunier; Alexander Steinkasserer; Stephan Becker; Paul Bates; Heike Hofmann; Stefan Pöhlmann
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Trehalose Inhibits Human Immunodeficiency Virus Type 1 Infection in Primary Human Macrophages and CD4+ T Lymphocytes through Two Distinct Mechanisms.

Authors:  Pratima Rawat; Simson Hon; Carmen Teodorof-Diedrich; Stephen A Spector
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

4.  Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor.

Authors:  J Roberto Trujillo; Rick Rogers; Ramon M Molina; Fernando Dangond; Mary Fran McLane; Max Essex; Joseph D Brain
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

5.  Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells.

Authors:  J E Vela Ramirez; R Roychoudhury; H H Habte; M W Cho; N L B Pohl; B Narasimhan
Journal:  J Biomater Sci Polym Ed       Date:  2014-07-28       Impact factor: 3.517

Review 6.  Cell biology of retroviral RNA packaging.

Authors:  Nolwenn Jouvenet; Sébastien Lainé; Lucie Pessel-Vivares; Marylène Mougel
Journal:  RNA Biol       Date:  2011-07-01       Impact factor: 4.652

7.  Short Communication: Inhibition of DC-SIGN-Mediated HIV-1 Infection by Complementary Actions of Dendritic Cell Receptor Antagonists and Env-Targeting Virus Inactivators.

Authors:  Sergey Pustylnikov; Rajnish S Dave; Zafar K Khan; Vanessa Porkolab; Adel A Rashad; Matthew Hutchinson; Frank Fieschi; Irwin Chaiken; Pooja Jain
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-18       Impact factor: 2.205

8.  HIV-1 uses dynamic podosomes for entry into macrophages.

Authors:  Wei Li; Ji Liu; Yuanyuan Liu; Qin Li; Wen Yin; Kevin K Wanderi; Xiaowei Zhang; Zhiping Zhang; Xian-En Zhang; Zongqiang Cui
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

10.  Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.

Authors:  Julie I Jay; Bonnie E Lai; David G Myszka; Alamelu Mahalingam; Kris Langheinrich; David F Katz; Patrick F Kiser
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.